Skip to content

Treatment Preferences and Decision-Making in Mental Health

Treatment Preferences and Decision-Making in Mental Health - nvt

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON39621
Enrollment
450
Registered
2012-04-12
Start date
2012-06-08
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

+ angststoornissen- en symptomen depression/ anxiety

Interventions

None listed

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients: 1. Sufficient proficiency in the Dutch language. 2. Age between 21 and 65 years. 3. Diagnosed with one or more mood and/or anxiety disorders. 4. Newly registered or recently under treatment for one or more mood and/or anxiety disorders;Clinicins 1. Employed as mental health practitioner by GGZ Rivierduinen or LUMC Psychiatric Department. 2. Licensed Psychiatrist (or resident) or clinical psychologist. 3. Experience with decision-making in the treatment of mood and anxiety disorders.

Exclusion criteria

Exclusion criteria: Patients: 1. Presence of manic and/or psychotic symptoms. 2. Other comorbid problems in the foreground (neurological, personality or addiction problems; suicidal tendency). 3. Severe social dysfunctioning (disabling the patient to come to appointments or a focus group meeting). 4. Participation not desirable in opion of the clinician, because of the severity of the patients illness and/or the burden of participating.

Design outcomes

Primary

MeasureTime frame
In the third stage of this study the following study parameters will be used to evaluate the newly developed decision aid: - Shared Decision Making, measured by the SDM-Q-9 (Shared Decision Making Questionaire) - Decisional Conflict, measured by the DCS (Decisional Conflict Scale) These parameters will be used to assess the effect of the decision aid on decison-making, by comparing the scores on these scales from patients and clinicians who used the decision aid, to scores of those who did not use it, measured in a earlier stage of the study.

Secondary

MeasureTime frame
nvt

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)